NCT01685606View on ClinicalTrials.gov

Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Mantle Cell LymphomaDiffuse Large Cell LymphomaBurkitts LymphomaT Cell LymphomasAcute Myeloid Leukemia/Acute Lymphoblastic Leukemia
Interventions
BIOLOGICAL

cellular immunotherapy

A minimum of 1x108 CD3+ cells and maximum of 2x108 CD3+ cells/kg from a haploidentical donor irrespective of the number of CD34+ cells will be infused.

Trial Locations (2)

02903

Rhode Island Hospital, Providence

The Miriam Hospital, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
lead

Brown University

OTHER